Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
about
Discs large (Dlg1) complexes in lymphocyte activationBcl10 can promote survival of antigen-stimulated B lymphocytesPKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1The riddle of the dual expression of IgM and IgDFlow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individualsThe quantal theory of how the immune system discriminates between "self and non-self"Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosomeThe Cbl interactome and its functionsDeciphering the pathway from the TCR to NF-kappaBEndocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells.A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cellsSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsMolecular basis of lysophosphatidic acid-induced NF-κB activationOvalbumin sensitization of guinea pig at birth prevents the ontogenetic decrease in airway smooth muscle responsiveness.Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.Axotrophin and leukaemia inhibitory factor (LIF) in transplantation toleranceA novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76.Compartmentalization in T-cell signalling: membrane microdomains and polarity orchestrate signalling and morphology.Defective B cell tolerance checkpoints in systemic lupus erythematosusB-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins.The use of genomewide ENU mutagenesis screens to unravel complex mammalian traits: identifying genes that regulate organ-specific and systemic autoimmunity.A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation.Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells.Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.Modulation of peripheral B cell tolerance by CD72 in a murine model.Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases.Regulation of autoreactive B cell responses to endogenous TLR ligands.Receptors, subcellular compartments and the regulation of peripheral B cell responses: the illuminating state of anergy.Phytoglycoprotein (75 kDa) suppresses release of histamine and expression of IL-4 and IFN- gamma in BPA-treated RBL-2H3 cells.CIN85 drives B cell responses by linking BCR signals to the canonical NF-kappaB pathway.A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes.Swiprosin-1/EFhd2 limits germinal center responses and humoral type 2 immunity.Cudrania tricupidata bureau (CTB) glycoprotein inhibits proliferation by Di(2-ethylhexyl) phthalate in primary splenocytes: responses in cell proliferation signaling.
P2860
Q24299762-832B04E9-27A6-4855-AFE8-DCFE2FE8EE28Q24301605-5DBF27E8-2D5E-4A4D-B839-8F0450571596Q24646391-BF14408B-6014-47C3-B0F1-8031FD546CECQ24682937-ADF7233E-4B13-4D00-8BD7-4AF0253A99F9Q24793329-4489A712-2A14-4C5C-AB77-26277A272E7CQ24803143-83041581-3DB2-410D-8B77-2DFC327FB422Q28115184-CD3F213C-DDD0-40D3-AC2D-6E4297BE7033Q28277251-2E025155-451A-49EF-92A1-10F857C48060Q28294015-9F7ACBF0-7308-45CC-BDE1-441FDEC4D2B0Q30486747-13CC0256-67CD-43BD-A525-F7139862FCE9Q33206929-E8787B54-C2BD-4B9A-AB13-5F4A50ECBAB3Q33298653-DDEA91FB-1B5F-47DB-9FE4-B2073DD2C3AAQ34055580-0E6770D5-D524-4381-84C9-429A5FE9B919Q34126537-81B79B58-2AEA-4877-A4D7-A193340F724BQ35094204-2FBB37B1-EE44-4661-8887-65BAF78060E1Q35596278-CF902CDD-2147-44A5-862A-180D86A3C743Q36251289-3DDD5F07-9E74-4824-A18D-F12BA21F7F09Q36267208-C61585F6-FBF9-4F76-B361-A295BD64F75FQ36365512-9A65ACB7-2530-483B-B7EC-772F86B72441Q36402748-C4163D58-9254-4EDC-8CA2-83906DF52314Q36446170-F4BD4BCF-DA7A-4A87-8DF7-31242EBD17FDQ36453343-B3378D3A-43FF-4F42-937C-3A1CC470D73FQ36596980-2E5E5E69-A690-4673-9888-3903AE9904BAQ36863105-9D845ED5-66FF-43F7-A350-AA358A0E9686Q37208247-8BF06398-71A7-4637-A544-A2DE87C1DACBQ37457141-8546D7EC-1E84-4545-B210-31992EA6E0FAQ37465464-A8A67035-0BF3-491F-A7B0-5A22A60436A2Q37650487-23730808-1581-4F0F-BBD9-C1D981457346Q37656307-E3FB7025-9724-4C7B-BF38-FD73B7970FE5Q37818686-9F9E74E9-7DAE-46DA-AA5F-CFCFD394D9B2Q39742975-A4E8D0AB-4062-45C8-9210-6CF733C377AAQ41789207-BE39EDD5-DCDC-49B7-92E4-A98941257977Q41983445-FAB491FD-0D98-49C3-BE4F-43ED113591D2Q42463478-2814B9DA-3980-432A-AA38-7D903D7B7853Q53268774-C738A88B-BDD7-4A0F-9A98-852CC635BF79
P2860
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
@ast
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
@en
type
label
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
@ast
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
@en
prefLabel
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
@ast
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.
@en
P2860
P356
P1433
P1476
Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling
@en
P2093
Jesse E Jun
P2860
P304
P356
10.1038/NI1001
P407
P577
2003-11-01T00:00:00Z